Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in NIKI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | JANE STREET GROUP, LLC | 58K | $46K | — | 0.921% | 0.00% |
| 2 | CITADEL ADVISORS LLC | 24K | $19K | -73.5% | 0.386% | 0.00% |
| 3 | CITIGROUP INC | 6K | $5K | — | 0.101% | 0.00% |
| 4 | OSAIC HOLDINGS, INC. | 6K | $4K | 0.0% | 0.087% | 0.00% |
| 5 | SBI Securities Co., Ltd. | 7 | $5 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in NIKI — a direct measure of their conviction.
Filings activity in NIKI during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new NIKI position in Q2 2026
Institutions that fully closed their NIKI position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 5 | 38% | 1.49% | 0.98 pp | $0M | 40% |
| Q1 2026 | 8 | +14% | 2.47% | +0.04 pp | $0M | 24% |
| Q4 2025 | 7 | +133% | 2.43% | +2.34 pp | $0M | +1335% |
| Q3 2025 | 3 | 25% | 0.09% | 0.52 pp | $0M | 67% |
| Q2 2025 | 4 | 56% | 0.61% | 0.88 pp | $0M | 56% |
| Q1 2025 | 9 | +80% | 1.49% | +0.74 pp | $0M | 41% |
| Q4 2024 | 5 | +67% | 0.75% | 0.12 pp | $0M | +34% |
| Q3 2024 | 3 | — | 0.87% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying NIKI stock.
Based on Q2 2026 13F filings, institutional ownership of Niki BioSolutions, Inc. stands at 1.5%, held across 5 reporting institutions.
JANE STREET GROUP, LLC is the largest reported institutional holder of NIKI, with approximately 58,461 shares worth $0.00B as of Q2 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of NIKI, including JANE STREET GROUP, LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for NIKI is 40 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
2 institutions opened new positions in NIKI during Q2 2026, while 5 fully exited. 0 added to existing positions and 3 trimmed.
NIKI institutional ownership fell by 0.98 percentage points quarter-over-quarter, with a net change of -3 holders.
The top 10 institutions account for 100.0% of all reported 13F value in NIKI, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Niki BioSolutions, Inc. (NIKI) Institutional Ownership